News

BioStat® Research
& Development Centre

2024 2023 2022 older
Biostat once again recognized in the Forbes ranking
21
May
2024
Biostat once again recognized in the Forbes ranking
For another year in a row, Biostat Research and Development Center has been recognized in the ranking of the most dyn...
Biostat and MSD Polska collaborate on lung cancer study
16
May
2024
Biostat and MSD Polska collaborate on lung cancer study
The Biostat Research and Development Centre starts cooperation with the MSD Polska pharmaceutical company. ...
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
16
May
2024
Biostat and MSD Polska collaborate on lung cancer study
16
May
2024

Biostat and MSD Polska collaborate on lung cancer study

The Biostat Research and Development Centre starts cooperation with the MSD Polska pharmaceutical company.

 

We will support our client from the administrative side in organizing and contracting a retrospective study conducted in the indication of lung cancer

- explains Edyta Klemba - Pharma Division Director at Biostat.

 

 

We are glad to be part of this project carried out by such a significant partner as MSD Polska,

adds Edyta Klemba.

 

MSD is a global pharmaceutical company with over 130 years of tradition. The company has been present in Poland for 33 years. MSD Poland currently has over 150 clinical trials open with nearly 4000 patients. The company has the status of a Research and Development Center granted to it over the last three years by the Minister of Development and Technology.

 

The key areas of clinical trials conducted by MSD are:

 

  1. oncological diseases,
  2. cardiovascular diseases (heart failure, hyperlipidemia, pulmonary arterial hypertension),
  3. vaccines for diseases caused by dangerous viruses such as HPV, RSV, pneumococci,
  4. antimicrobial treatment (bacterial and fungal infections, Covid-19, HIV),
  5. autoimmune diseases (lupus, ulcerative colitis, Crohn's disease).



> Clinical trials implemented by Biostat - read more

 

Copyright© 2023 Biostat
Cookies